|
CN105055570A
|
|
Blood lipid lowering Chinese medicinal composition, preparation and preparation technology thereof
|
|
CN105148812A
|
|
Treatment device and treatment method for laboratory liquid preparation
|
|
CN105001140A
|
|
Preparation method and application of fatty dioic acid derivative
|
|
CN104892749A
|
|
Preparation method and application of insulin degludec crystal
|
|
CN104761632A
|
|
Preparation method and application of insulin detemir crystal
|
|
CN104267137A
|
|
Quantitative analysis method of methyl mercaptan in levetiracetam
|
|
CN104402848A
|
|
Preparation method of impurity compound in ramelteon and prepared standard substance
|
|
CN104165957A
|
|
Method for determining content of bipolymer impurities in faropenem sodium
|
|
CN105272985A
|
|
Triazolo[4,5-d]pyrimidine compound and synthesis method, application and composition thereof
|
|
CN104950047A
|
|
Method for detecting content, dissolution rate and releasing rate of memantine hydrochloride or analogues thereof in medicinal agent
|
|
CN103694339A
|
|
Renaturation method of insulin glargine precursor
|
|
CN103342746A
|
|
Method for preparing stable insulin aspart crystal
|
|
CN103305581A
|
|
Preparation method of recombinant human insulin
|
|
CN103290083A
|
|
Preparation method of human insulin esters
|
|
CN103275210A
|
|
Chromatographic purification method of fatty acid mono-acylation insulin
|
|
CN103275960A
|
|
Manually designed penicillin G acylation zymogen, coding sequence and fermentation method
|
|
CN102336771A
|
|
Method for preparing sulfuric acid cefoselis intermediate
|
|
CN102207492A
|
|
Quantitative analysis method for biapenem dimer in biapenem
|
|
CN102652750A
|
|
Pharmaceutical composition containing cefuroxime, preparation of composition, and preparation method of composition
|
|
CN102070568A
|
|
Preparation method of orlistat
|
